CDC Awards BioCryst $35 Million RAPIVAB Contract for Strategic National Stockpile
BioCryst Pharmaceuticals announced that the Centers for Disease Control and Prevention (CDC) has awarded BioCryst a $34.7 million contract for the procurement of up to 50,000 doses of…
Read More...
Read More...
